09 June 2025
King's MedTech Accelerator 2025 cohort announced
The King’s MedTech Accelerator, a programme focused on transforming research innovations into viable healthcare ventures, has accepted 26 projects into its 2025 cohort.
The 6-month, part-time programme supports aspiring entrepreneurs from across King's College London and King’s Health Partners focused on transforming research innovations into viable healthcare ventures.
The King’s MedTech Accelerator is delivered by the School of Biomedical Engineering & Imaging Sciences at the London Institute for Healthcare Engineering (LIHE), the centre for MedTech translation at King’s. Programme participants will be supported through monthly mentorship sessions, consolidating their learning and addressing venture-specific challenges in real time.
Now in its second year, the King’s MedTech Accelerator received a record 70 applications – a 65% increase on the number of applicants in 2024. The programme has expanded to include specialist support for Digital Health innovation projects from 2025. It will also cater specifically to solutions with a strong digital element that treat, diagnose, or predict health outcomes.
Projects were accepted from the faculties of Life Sciences and Medicine (FoLSM); Natural, Mathematical & Engineering Sciences (NMES); Dentistry, Oral & Craniofacial Sciences (FoDOCS); the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) and King’s Health Partners (KHP).
Congratulations to the following projects:
Learn more about the projects here.
Over the next six months, the cohort will benefit from the specialist teams at LIHE to develop entrepreneurship skills for advancing medical technologies. This includes tailored workshops, menortship and expert-led sessions for MedTech including regulatory considerations, healthcare economics, value proposition design, and market analysis. Participants will also receive training on how to assemble interdisciplinary teams, seek funding and partnerships, and effectively communicate to navigate the MedTech venture journey.
The programme embodies King’s commitment to advancing MedTech innovations for real-world impact and is supported by King’s Innovation Catalyst and the King’s Entrepreneurship Institute.